Litigation Details for AbbVie Inc. v. Alvotech hf. (N.D. Ill. 2021)
✉ Email this page to a colleague
AbbVie Inc. v. Alvotech hf. (N.D. Ill. 2021)
| Docket | ⤷ Sign Up | Date Filed | 2021-04-27 |
| Court | District Court, N.D. Illinois | Date Terminated | 2022-03-09 |
| Cause | 35:271 Patent Infringement | Assigned To | John Zihun Lee |
| Jury Demand | Defendant | Referred To | |
| Parties | ABBVIE INC. | ||
| Patents | 8,231,876; 8,420,081; 8,663,945; 8,715,664; 8,808,700; 8,883,156; 8,889,136; 8,895,009; 8,906,372; 8,906,373; 8,906,646; 8,911,964; 8,916,153; 8,926,975; 8,961,973; 8,961,974; 8,986,693; 8,999,337; 9,061,005; 9,062,106; 9,067,992; 9,085,618; 9,085,619; 9,085,620; 9,090,688; 9,090,689; 9,090,867; 9,096,666; 9,102,723; 9,150,645; 9,181,337; 9,181,572; 9,187,559; 9,234,032; 9,266,949; 9,273,132; 9,284,370; 9,284,371; 9,290,568; 9,315,574; 9,328,165; 9,334,319; 9,346,879; 9,359,434; 9,499,614; 9,499,616; 9,505,834; 9,512,216; 9,522,953; 9,550,826; 9,624,295; 9,669,093; 9,683,033; 9,708,400; 9,957,318 | ||
| Attorneys | Linhong Zhang | ||
| Firms | Jenner & Block, LLP | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in AbbVie Inc. v. Alvotech hf.
The biologic drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .
Details for AbbVie Inc. v. Alvotech hf. (N.D. Ill. 2021)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2021-04-27 | 1 | complaint | Protector Shroud 2. 8,231,876 Wan Purified… AbbVie’s patents at the Patent Trial and Appeal Board (“PTAB”) of the United States Patent and Trademark… AbbVie patents (AbbVie removed one of the patents from its prior list) and that those patent claims … U.S. Patent No. 8,420,081 63. U.S. Patent No. 8,420,081 (the “’081 patent”), titled “… U.S. Patent No. 8,926,975 68. U.S. Patent No. 8,926,975 (the “’975 patent”), titled “ | External link to document |
| 2021-11-18 | 101 | other | proceeding involving the ’619 patent’s parent, U.S. Patent No. 8,420,081, lends further support to “water…indefinite, with terms in the ’792 patent being the most egregious. That patent, which AbbVie asserts covers…’s so-called “bufferless” patents, one of which, in violation of the Patent Dance confidentiality provisions… ARGUMENT The ’792 Patent The ’792 patent relates to methods for purifying … The ’619 and ’030 Patents The ’619 and ’030 patents share a common specification2 | External link to document |
| 2021-09-14 | 60 | answer to complaint | Protector Shroud 2. 8,231,876 Wan Purified…the ’081 patent, the ’975 patent, the ’973 patent, and the ’619 patent or any related patent because …the ’081 patent, the ’975 patent, the ’973 patent, and the ’619 patent due to Plaintiffs’ patent misuse…enforceable claim of the ’081 patent, the ’975 patent, the ’973 patent, and the ’619 patent, either literally or… claim of the ’081 patent, the ’975 patent, the ’973 patent, and the ’619 patent is invalid for failing | External link to document |
| 2021-09-20 | 63 | order | U.S. Patent No. 8,420,081 as one of the Ten Patents; and (3) the patent issuing from U.S. Patent Application…02889 to add (1) U.S. Patent No. 11,083,792; (2) the patent issuing from U.S. Patent Application No. 17/… related to the ten patents that will be subject to a first trial (“Ten Patents”)1, IT IS HEREBY ORDERED…9,187,559, 9,512,216, 11,083,792, and the patent issuing from U.S. Patent Application No. 17/137,201. Case…seek a preliminary injunction on any patents other than the Ten Patents. Plaintiffs shall not seek a preliminary | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
